Seems like there is something wrong with company and market knows it. Alas for small investors things aren’t public yet.
I have a decent exposure in Aurobindo and still fell that this is one of the better companies to invest in.
The stock has been bought by more schemes than actually sold. Also the fundamentals seem strong. There is of course always the issue of US markets but that is not specific to Aurobindo.
Aurobindo gets final USFDA approval for gReyataz
Why are people depressed about this stock when among its peers, its least affected by US FDA regulations ? On the contrary, commentary on aurobindo is mostly positive.
Is the recent depreciation in rupee that is helping the recent surge in Aurobindo or there are other reasons. I have been reading about the acquisitions of course but that has been going on for some time now.
stock has fell down approx. 8% to 9% from nearly 52 week high
is this an opportunity to buy or early warning for upcoming fall in Aurobindo
Helix Healthcare (subsidiary of Aurobindo) entered into a JV with Shandong Luoxin Pharmaceutical Group China to manufacture nebuliser inhaler and other products for China, US and EU markets. This would be operational in 2021.
Though the addressable market for respiratory related therapies is fairly small as per Aurobindo at ~$0.5Bn.
Any idea of the financial impact due to lawsuit?